Large-scale testing (Phase 3)Looking for participantsNCT06640361What this trial is testingOlverembatinib in SDH-deficient GIST.Who this might be right forGIST Ascentage Pharma Group Inc. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07443488What this trial is testingEfficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALLWho this might be right forHSCTPh+ ALL Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05931757What this trial is testingOlverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALLWho this might be right forPhiladelphia-Positive ALL The First Affiliated Hospital of Soochow University 22
Testing effectiveness (Phase 2)Looking for participantsNCT06757855What this trial is testingOlverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CMLWho this might be right forCML,Blast Phase Institute of Hematology & Blood Diseases Hospital, China 29
Testing effectiveness (Phase 2)Looking for participantsNCT06754267What this trial is testingVenetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALLWho this might be right forPrecursor B-Cell Acute Lymphoblastic Leukemia First Affiliated Hospital of Zhejiang University 36
Testing effectiveness (Phase 2)UnknownNCT05466175What this trial is testingOlverembatinib in the Treatment of Ph+ ALLWho this might be right forPhiladelphia-Positive ALL Chen Suning 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06658925What this trial is testingOlverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALLWho this might be right forPh+ Acute Lymphoblastic Leukemia (Ph+ALL)HSCTTyrosine Kinase Inhibitor Institute of Hematology & Blood Diseases Hospital, China 50
Very early researchLooking for participantsNCT07074496What this trial is testingEfficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.Who this might be right forPhiladelphia Chromosome-Positive Acute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)UnknownNCT03883100What this trial is testingA Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I MutationWho this might be right forChronic Myeloid Leukemia - Accelerated Phase Ascentage Pharma Group Inc. 23
Not applicableUnknownNCT05603156What this trial is testingOlverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent PositiveWho this might be right forPh+ ALLBone Marrow TransplantMinimal Residual Disease Institute of Hematology & Blood Diseases Hospital, China 46
Not applicableAvailableNCT05594758What this trial is testingNamed Patient Program for Olverembatinib (HQP1351) Ascentage Pharma Group Inc.
Large-scale testing (Phase 3)Looking for participantsNCT06423911What this trial is testingStudy of Olverembatinib (HQP1351) in Patients With CML-CPWho this might be right forChronic Myeloid LeukemiaCMLCML, Chronic Phase Ascentage Pharma Group Inc. 333
Early research (Phase 1)Looking for participantsNCT05495035What this trial is testingStudy for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALLWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodLeukemia, Lymphoblastic, Acute, Philadelphia-PositiveRelapsed Leukemia+1 more Institute of Hematology & Blood Diseases Hospital, China 19
Early research (Phase 1)Looking for participantsNCT06401603What this trial is testingA Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid LeukemiaWho this might be right forAdvanced Chronic Myeloid LeukemiaPhiladelphia Chromosome-Positive Acute Myeloid Leukemia M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06220487What this trial is testingA Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALLWho this might be right forAcute Lymphoblastic LeukemiaPhiladelphia ChromosomePhiladelphia-Positive ALL+2 more Nanfang Hospital, Southern Medical University 67
Testing effectiveness (Phase 2)Looking for participantsNCT06817720What this trial is testingPhase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forChronic Myeloid Leukemia M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)UnknownNCT03883087What this trial is testingA Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I MutationWho this might be right forChronic Myeloid Leukemia, Chronic Phase Ascentage Pharma Group Inc. 41
Not applicableLooking for participantsNCT06481228What this trial is testingEfficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALLWho this might be right forPhiladelphia Positive Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, Adult Institute of Hematology & Blood Diseases Hospital, China 82
Large-scale testing (Phase 3)Looking for participantsNCT07152041What this trial is testingNewly-diagnosed Pediatric Ph-positive B-ALL ProtocolWho this might be right forAcute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Childhood Leukemia, Acute Lymphoblastic Institute of Hematology & Blood Diseases Hospital, China 150
Not applicableEnrolling By InvitationNCT07383298What this trial is testingObservational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated PhaseWho this might be right forChronic Myeloid Leukemia Qian Jiang 100